产品详情
查看大图

  • 产品名称：ATCC 25285 脆弱拟杆菌

  • 产品型号：ATCC 25285
  • 产品厂商：其它品牌
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
简单介绍 ATCC 25285 脆弱拟杆菌，现货供应 ATCC 菌种 上海桑戈生物公司现货供应美国典型培养物保藏中心(ATCC)菌种。,*低价格,所谓"踏破铁鞋无觅处.得来全不费工夫!"联系电话021-55221162手机 13661616642邮箱sangerbio @hotmail.com.欢迎各位老师来电咨! 美国菌种保藏中心
详情介绍：

ATCC 25285 脆弱拟杆菌 的详细介绍
ATCC 25285 脆弱拟杆菌
ATCC® Number:   25285™        
Preceptrol® Culture  
Organism:  Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers 
Designations:  VPI 2553 [EN-2; NCTC 9343]  
Isolation:  Appendix abscess  
Depositor:  WE Moore  
History:  ATCC <<--WE Moore<<--A. Sonnenwirth EN-2 <<--- NCTC 9343 <<--- L. Garrod  
Biosafety Level:  2  
Shipped:  freeze-dried  
Growth Conditions:  ATCC medium1490: Modified chopped meat medium
Temperature: 37.0°C 
Duration: anaerobic  
Permits/Forms:  In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.  
Cross References:  Nucleotide (GenBank) : AF280705 Bacteroides fragilis isolate ATCC 25285 RecA (recA) gene, partial cds.
Nucleotide (GenBank) : AX110196 Sequence 929 from Patent WO0123604.
Nucleotide (GenBank) : X83935 B.fragilis 16S rRNA (ATCC 25285T).
Nucleotide (GenBank) : CR626927Bacteroides fragilis NCTC 9343, complete genome.
Nucleotide (GenBank) : AF280642 Bacteroides fragilis isolate ATCC 25285 glutamine synthetase (glnA) gene, partial cds.
Nucleotide (GenBank) : U05887 Bacteroides fragilis ATCC 25285 beta-lactamase (cepA-85) gene, complete cds.  
Type Strain:  yes(type strain)  
Comments:  Genome sequenced strain  
Applications:  media testing [92430] [21529] 
quality control [92216] 
quality control strain [92125] [92162] [92152] 
susceptibility testing [21527] 
quality control strain for BBL and MicroScan [Reg TM] products  
Related Products:  purified DNA:ATCC 25285D  
References:  6005: Cato EP, Johnson JL. Reinstatement of species rank for Bacteroides fragilis, B. ovatus, B. distasonis, B. thetaiotaomicron, and B. vulgatus: Designation of neotype strains for Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers and Bacteroides thetaiotaomicron (Distaso) Castellani and Chalmers. Int. J. Syst. Bacteriol. 26: 230-237, 1976.
21527: CLSI Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M11-A7.
21529: CLSI Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M22-A3.
36887: Skerman VB, et al. Approved lists of bacterial names. Int. J. Syst. Bacteriol. 30: 225-420, 1980.
39924: Takahata M, Nishino T. Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects. Chemotherapy 43: 153-158, 1997. PubMed: 9142454
92125: BD Crystal ANR. :BD Becton Dickinson;Crystal
92152: MicroScan Rapid Anaerobic Panel. :Dade Behring;MicroScan
92162: Sensititre Anaerobe MIC Susceptibility. :Trek Diagnostic Systems;Sensititre
92216: CLSI Quality Control of Microbiological Transport Systems; Approved Standard. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M40-A.
92430: Medical microbiology--Culture media -- Part 4: Transport systems for specimens containing bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58942-4: 2003, 2003 

沪公网安备 31010902002433号